Systematic review tracks global rise of enterovirus D68 cases and paralysis risk
- **A systematic review of data from 2015 to 2024 found that 8,184 cases of enterovirus D68 were reported across 44 countries.
- Of these, 267 cases involved acute flaccid paralysis, highlighting the virus's continued circulation and severity in both children and adults.**
- A total of 8,184 enterovirus D68 cases were identified, including 267 cases (3.3%) of EV-D68-associated acute flaccid paralysis.
- Biennial upsurges followed an every-even-year pattern until 2020, after which circulation patterns diversified geographically in Europe and North America.
- The virus remained associated with severe respiratory disease and acute flaccid myelitis, affecting not only children younger than five years but increasingly adults as well.
The publication
**A systematic review of data from 2015 to 2024 found that 8,184 cases of enterovirus D68 were reported across 44 countries. Of these, 267 cases involved acute flaccid paralysis, highlighting the virus's continued circulation and severity in both children and adults.**
Who the findings apply to
The analysis included data from 44 countries reporting enterovirus D68 cases between 2015 and 2024. The reported cases spanned all continents, with acute flaccid paralysis cases specifically documented in 26 countries.
Why this matters
The review synthesizes global data to show that enterovirus D68 remains a persistent health concern causing respiratory disease and rare but severe paralytic syndromes. The findings indicate a shift in circulation patterns following 2020, with geographical diversification in Europe and North America possibly linked to the COVID-19 pandemic. Understanding these epidemiological trends and genetic shifts is critical for sustaining surveillance and improving diagnostic strategies to mitigate morbidity.
What the study found
A total of 8,184 enterovirus D68 cases were identified, including 267 cases (3.3%) of EV-D68-associated acute flaccid paralysis. Biennial upsurges followed an every-even-year pattern until 2020, after which circulation patterns diversified geographically in Europe and North America. The virus remained associated with severe respiratory disease and acute flaccid myelitis, affecting not only children younger than five years but increasingly adults as well.
Genotypic analysis showed the dominance of subgenotype B3 since 2016 and A2/D since 2018. Novel variants emerged for both genotypes after 2020. Individuals who progressed to acute flaccid paralysis had a poor prognosis for full recovery.
What the result does not establish
The authors note limitations in surveillance quality and coverage, which may affect the completeness of the global data. The review relies on reported cases from participating countries, potentially underrepresenting regions with limited diagnostic capacity or reporting infrastructure.
Authors’ conclusion
“Genotypic shifts were marked by the dominance of subgenotype B3 since 2016 and A2/D since 2018, with novel variants emerging for both after 2020. Despite limitations in surveillance quality and coverage, the findings underscore the need for sustained surveillance, improved diagnostic strategies, and targeted interventions to mitigate EV-D68-related morbidity.”
Study and sources
Global epidemiology and genetic evolution of enterovirus D68 over a decade (2015-24): a systematic review
Systematic review / meta-analysis · Lancet Microbe · 2026-11-17
Sources and limitations
- PubMed record PMID 43044622 (PubMed / NLM · 2026-11-20)
Related briefings
Follow ENCLAI News
Get new briefings in your news reader. No ENCLAI account needed.
The daily disease brief
One email a day: what changed in official disease reporting worldwide, with the source named for every number. Reported facts only — no forecasts and no interpretation.


